- Search results for 1089283-49-7
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
3 products were found matching "1089283-49-7"!
Close filters
Filter by:
No results were found for the filter!
Item number: TGM-T6003-10mg
Description: GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) . Target: IGF-1R, Apoptosis, Raf, Syk, VEGFR. Smiles: CCc1cc(Nc2nccc(n2)-c2c(nc3ccccn23)-c2ccc(OC)c(c2)C(=O)Nc2c(F)cccc2F)c(OC)cc1N1CCC(CC1)N1CCN(CC1)S(C)(=O)=O. References: Sabbatini P, et al. Clin Cancer Res,...
Keywords: | GSK 4529 |
Application: | Insulin receptor / IGF-1R dual inhibitor |
CAS | 1089283-49-7 |
MW: | 851.96 D |
From 36.00€
*
Item number: LKT-G7541.1
GSK-1904529A is an inhibitor of the insulin receptor (InsR) and IGF-1R that exhibits anticancer chemotherapeutic activity. In cellular and animal models of multiple myeloma and Ewing's sarcoma, GSK-1904529A induces cell cycle arrest and inhibits cell proliferation and tumor growth.
Keywords: | GSK1904529A |
Application: | InsR / IGF-1R inhibitor |
CAS | 1089283-49-7 |
MW: | 851.96 D |
From 164.00€
*
Item number: Cay29155-1
GSK1904529A is a dual inhibitor of the insulin receptor (InsR) and insulin-like growth factor 1 receptor (IGF-1R) kinases (IC50s = 25 and 27 nM, respectively, in a cell-free assay). It selectively inhibits InsR and IGF-1R kinases over a panel of 45 serine/threonine and tyrosine kinases (IC50s = >1 µM for all)....
Keywords: | N-(2,6-difluorophenyl)-5-[3-[2-[[5-ethyl-2-methoxy-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-p... |
Application: | Insulin receptor / IGF-1R dual inhibitor |
CAS | 1089283-49-7 |
MW: | 852 D |
From 44.00€
*